Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method (DNA Methylation), Technique (NGS, PCR, Mass Spectrometry), Application (Oncology, Immunology) - Global Forecast to 2028
The global epigenetics market size is projected to reach USD 4.3 billion by 2028 from USD 1.8 billion in 2023, at a CAGR of 18.3% during the forecast period. Factors such as increased investments in research and development, coupled with a reduction in sequencing costs and time, support from government initiatives and funding for epigenetics research, advancements in technology for epigenetic research, and a growing interest in epigenetic-based therapeutics.
“The kits & reagents segment segment held the dominant share in the epigenetics market”
Based on product & service, the global epigenetics market is segmented into kits & reagents, enzymes, instruments and accessories, software, and service. The kits & reagents segment is anticipated to grow at significant CAGR. The rapid expansion of epigenetics studies, combined with the introduction of cost-effective and user-friendly kits by market participants are likely to have positive impact on the growth of the market.
“DNA methylation segment accounted for the largest share of the method segment in 2022.”
Based on method, the epigenetics market is segmented into, DNA methylation, histone modifications, and other methods. In 2022, the DNA methylation segment accounted for the largest share of the epigenetics market. The segment held the dominant share in the market owing to the effectiveness of employing DNA methylation techniques for cancer research.
“Asia Pacific region is likely to grow at a faster pace in the epigenetics market.”
The epigenetics market region is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and the Africa. Asia Pacific region is anticipated to grow at a significant CAGR during the forecast period. The growth of the region is majorly driven by enhancements in healthcare infrastructure within developing APAC economies, coupled with strategic partnerships, collaborations, agreements, and expansions pursued by local industry players.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the epigenetics market. It aims at estimating the size and future growth potential of the market across different segments such as the technology, type, disease indication, route of administration, end-user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall epigenetics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
“The kits & reagents segment segment held the dominant share in the epigenetics market”
Based on product & service, the global epigenetics market is segmented into kits & reagents, enzymes, instruments and accessories, software, and service. The kits & reagents segment is anticipated to grow at significant CAGR. The rapid expansion of epigenetics studies, combined with the introduction of cost-effective and user-friendly kits by market participants are likely to have positive impact on the growth of the market.
“DNA methylation segment accounted for the largest share of the method segment in 2022.”
Based on method, the epigenetics market is segmented into, DNA methylation, histone modifications, and other methods. In 2022, the DNA methylation segment accounted for the largest share of the epigenetics market. The segment held the dominant share in the market owing to the effectiveness of employing DNA methylation techniques for cancer research.
“Asia Pacific region is likely to grow at a faster pace in the epigenetics market.”
The epigenetics market region is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and the Africa. Asia Pacific region is anticipated to grow at a significant CAGR during the forecast period. The growth of the region is majorly driven by enhancements in healthcare infrastructure within developing APAC economies, coupled with strategic partnerships, collaborations, agreements, and expansions pursued by local industry players.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 60%, and Demand Side - 40%
- By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
- By Region: North America: 40%, Europe: 27%, Asia Pacific: 20%, Latin America: 10%, and the Middle East & Africa: 3%
- Thermo Fisher Scientific Inc. (US)
- Merck KGaA (Germany)
- Illumina, Inc. (US)
- PacBio (US)
- Abcam plc (UK)
- Active Motif, Inc. (US)
- Bio-Rad Laboratories Inc. (US)
- Promega Corporation (US)
- Revvity (US)
- Qiagen (Germany)
- New England Biolabs (US)
- Zymo Research Corporation (US)
- Diagenode SA(US)
- F. Hoffmann-La Roche Ltd (Switzerland)
- EpiGentek Group Inc. (US)
- EpiCypher (US)
- Fios Genomics (UK)
- GenomeScan (Netherlands)
- Creative Biogene (US)
- BPS Bioscienc Inc (US)
- Abnova Corporation (Taiwan)
- Creative Diagnostics (US)
- Biomodal (UK)
- Integrated DNA Technologies Inc. (US)
- Novogene Co Ltd (China)
This report provides a detailed picture of the epigenetics market. It aims at estimating the size and future growth potential of the market across different segments such as the technology, type, disease indication, route of administration, end-user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall epigenetics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (growing investment in research & development, declining sequencing cost & time, favorable government initiatives and funding for epigenetics research, technological advancements in epigenetic research and rising demand for epigenetic-based therapeutics), restraints (Limited application of epigenomic data in toxicology, data privacy concern and security issues associated with management of large scale- epigenetic data ), opportunities (Expanding application of epigenetics and integration of artificial intelligence and machine learning algorithm) and challenges (Concerns Regarding the Quality of Antibodies, Challenges associated epigenetics editing, off target effect) are influencing the growth of epigenetics market.
- Product Development/Innovation: Detailed insights on newly launched products of the epigenetics market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the epigenetics market across varied regions.
- Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the epigenetics market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Abcam plc (UK), Active Motif, Inc. (US), Bio-Rad Laboratories Inc. (US), Promega Corporation (US), Revvity (US) and Qiagen (Germany).
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 RESEARCH LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION: EPIGENETICS MARKET (2022)
FIGURE 4 APPROACH 1: REVENUE SHARE ANALYSIS
FIGURE 5 REVENUE SHARE ANALYSIS OF THERMO FISHER SCIENTIFIC INC.: EPIGENETICS MARKET (2022)
2.2.1 PRIMARY INSIGHTS
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENTAL ASSESSMENT: EPIGENETICS MARKET
FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
FIGURE 8 CAGR PROJECTION: EPIGENETICS MARKET
FIGURE 9 GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT: EPIGENETICS MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2021–2028 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 11 EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 EPIGENETICS MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)
FIGURE 13 EPIGENETICS MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
FIGURE 14 EPIGENETICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 15 EPIGENETICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF EPIGENETICS MARKET
4 PREMIUM INSIGHTS
4.1 EPIGENETICS MARKET OVERVIEW
FIGURE 17 DECLINING SEQUENCING COSTS & TIME TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
4.2 NORTH AMERICA: EPIGENETICS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 18 KITS & REAGENTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN EPIGENETICS MARKET IN 2022
4.3 EPIGENETICS MARKET SHARE, BY PRODUCT & SERVICE, 2023 VS. 2028
FIGURE 19 KITS & REAGENTS SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
4.4 EPIGENETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATES FROM 2023 TO 2028
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 EPIGENETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 IMPACT ANALYSIS: EPIGENETICS MARKET
5.2.1 DRIVERS
5.2.1.1 Growing investments in research & development
5.2.1.2 Declining sequencing costs & time
FIGURE 22 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2020
5.2.1.3 Favorable government initiatives and funding for epigenetics research
5.2.1.4 Technological advancements in epigenetics research
5.2.1.5 Rising demand for epigenetic-based therapeutics
FIGURE 23 NUMBER OF CANCER CASES IN US, 2017–2022
5.2.2 RESTRAINTS
5.2.2.1 Limited applications of epigenomic data in toxicology
5.2.2.2 Data privacy concerns and security issues
5.2.3 OPPORTUNITIES
5.2.3.1 Expanding applications of epigenetics
5.2.3.2 Integration of artificial intelligence and machine learning algorithms
5.2.4 CHALLENGES
5.2.4.1 Concerns regarding quality of antibodies
5.2.4.2 Challenges associated with epigenetic editing
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 REVENUE SHIFT AND NEW REVENUE POCKETS FOR EPIGENETICS PROVIDERS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE OF PRODUCTS, BY KEY PLAYER
TABLE 5 AVERAGE SELLING PRICE OF PRODUCTS, BY KEY PLAYER
5.4.2 AVERAGE SELLING PRICE TREND
5.5 TECHNOLOGY ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASES CONTRIBUTE MAXIMUM VALUE
5.7 ECOSYSTEM MAP
FIGURE 26 ECOSYSTEM MAP
TABLE 6 ROLE IN ECOSYSTEM: EPIGENETICS MARKET
5.8 REGULATORY ANALYSIS
TABLE 7 KEY REGULATORY AGENCIES
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 MIDDLE EAST: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 14 PORTER’S FIVE FORCES ANALYSIS: EPIGENETICS MARKET
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 PATENT ANALYSIS
FIGURE 27 PATENT APPLICATIONS FOR EPIGENETICS, NOVEMBER 2013–NOVEMBER 2023
TABLE 15 INDICATIVE LIST OF PATENTS: EPIGENETICS MARKET
5.11 KEY CONFERENCES & EVENTS
TABLE 16 DETAILED LIST OF KEY CONFERENCES & EVENTS, 2023–2024
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EPIGENETICS
5.12.2 BUYING CRITERIA FOR EPIGENETICS
FIGURE 29 KEY BUYING CRITERIA FOR END USERS
6 EPIGENETICS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 17 EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 KITS & REAGENTS
TABLE 18 EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 19 EPIGENETICS MARKET FOR KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 20 NORTH AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 ANTIBODIES
6.2.1.1 Growing demand for recombinant antibodies for detection of epigenetic targets to propel growth
TABLE 24 EPIGENETICS MARKET FOR ANTIBODIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 25 NORTH AMERICA: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 EUROPE: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 LATIN AMERICA: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 CHIP-SEQUENCING KITS & REAGENTS
6.2.2.1 Versatile applications of chromatin immunoprecipitation (ChIP) pertaining to epigenetic regulatory systems to boost demand
TABLE 29 EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 NORTH AMERICA: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 EUROPE: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 ASIA PACIFIC: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 LATIN AMERICA: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 BISULFITE CONVERSION KITS & REAGENTS
6.2.3.1 Effective outcomes associated with bisulfite conversion to drive demand
TABLE 34 EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 LATIN AMERICA: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 WHOLE-GENOME AMPLIFICATION KITS & REAGENTS
6.2.4.1 Ability of whole-genome amplification to maintain relative proportions of genes in original pool to drive adoption
TABLE 39 EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 40 NORTH AMERICA: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 EUROPE: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 ASIA PACIFIC: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 LATIN AMERICA: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.5 5-HMC & 5-MC ANALYSIS KITS & REAGENTS
6.2.5.1 Introduction of unique kits for 5-mC and 5-hmC analysis to support growth
TABLE 44 EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 45 NORTH AMERICA: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 EUROPE: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 ASIA PACIFIC: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 LATIN AMERICA: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.6 HISTONES
6.2.6.1 Emerging importance of chromatin-associated proteins and histones in epigenetic research to drive segmental growth
TABLE 49 EPIGENETICS MARKET FOR HISTONES, BY REGION, 2021–2028 (USD MILLION)
TABLE 50 NORTH AMERICA: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 51 EUROPE: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 ASIA PACIFIC: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 LATIN AMERICA: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.7 OTHER KITS & REAGENTS
TABLE 54 EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 55 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 56 EUROPE: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 ENZYMES
TABLE 59 EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 60 EPIGENETICS MARKET FOR ENZYMES, BY REGION, 2021–2028 (USD MILLION)
TABLE 61 NORTH AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 DNA-MODIFYING ENZYMES
6.3.1.1 Broadening applications of DNA methylation to favor market growth
TABLE 65 EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY REGION, 2021–2028 (USD MILLION)
TABLE 66 NORTH AMERICA: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 EUROPE: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 ASIA PACIFIC: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 LATIN AMERICA: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 PROTEIN-MODIFYING ENZYMES
6.3.2.1 Increasing pipeline of epigenetics-based drugs targeting histone-modifying enzymes to drive segmental growth
TABLE 70 EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY REGION, 2021–2028 (USD MILLION)
TABLE 71 NORTH AMERICA: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 72 EUROPE: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 ASIA PACIFIC: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 LATIN AMERICA: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 OTHER ENZYMES
TABLE 75 EPIGENETICS MARKET FOR OTHER ENZYMES, BY REGION, 2021–2028 (USD MILLION)
TABLE 76 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 77 EUROPE: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 INSTRUMENTS & ACCESSORIES
6.4.1 WIDE USAGE OF NGS INSTRUMENTS AND SONICATORS TO PROPEL GROWTH
TABLE 80 EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 81 NORTH AMERICA: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 EUROPE: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 ASIA PACIFIC: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 LATIN AMERICA: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 SOFTWARE
6.5.1 DEVELOPMENT OF VIABLE SOFTWARE SOLUTIONS FOR DNA METHYLATION AND RNA ANALYSIS TO PROPEL GROWTH
TABLE 85 EPIGENETICS MARKET FOR SOFTWARE, BY REGION, 2021–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 EUROPE: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 LATIN AMERICA: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
6.6 SERVICES
6.6.1 EXPANDING POOL OF SERVICE PROVIDERS TO DRIVE GROWTH
TABLE 90 EPIGENETICS MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION)
TABLE 91 NORTH AMERICA: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 EUROPE: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 ASIA PACIFIC: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 LATIN AMERICA: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
7 EPIGENETICS MARKET, BY METHOD
7.1 INTRODUCTION
TABLE 95 EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
7.2 DNA METHYLATION
7.2.1 INCREASING R&D ACTIVITIES TO EXPLORE POTENTIAL OF DNA METHYLATION TO DRIVE MARKET GROWTH
TABLE 96 EPIGENETICS MARKET FOR DNA METHYLATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 98 EUROPE: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 ASIA PACIFIC: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 LATIN AMERICA: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 HISTONE MODIFICATIONS
7.3.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE SEGMENTAL GROWTH
TABLE 101 COMMON HISTONE MODIFICATIONS AND RESPECTIVE LOCATIONS
TABLE 102 EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 103 NORTH AMERICA: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 106 LATIN AMERICA: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 OTHER METHODS
TABLE 107 EPIGENETICS MARKET FOR OTHER METHODS, BY REGION, 2021–2028 (USD MILLION)
TABLE 108 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 109 EUROPE: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2021–2028 (USD MILLION)
8 EPIGENETICS MARKET, BY TECHNIQUE
8.1 INTRODUCTION
TABLE 112 EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
8.2 NGS
8.2.1 ABILITY TO OFFER COMPREHENSIVE EPIGENETIC PROFILES TO PROPEL DEMAND FOR NGS TECHNIQUE
TABLE 113 EPIGENETICS MARKET FOR NGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 114 NORTH AMERICA: EPIGENETICS MARKET FOR NGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 115 EUROPE: EPIGENETICS MARKET FOR NGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 116 ASIA PACIFIC: EPIGENETICS MARKET FOR NGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 LATIN AMERICA: EPIGENETICS MARKET FOR NGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 PCR & QPCR
8.3.1 RISING NUMBER OF PCR-BASED EPIGENETICS SERVICE PROVIDERS TO DRIVE GROWTH
TABLE 118 EPIGENETICS MARKET FOR PCR & QPCR, BY REGION, 2021–2028 (USD MILLION)
TABLE 119 NORTH AMERICA: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 120 EUROPE: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 ASIA PACIFIC: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 LATIN AMERICA: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 MASS SPECTROMETRY
8.4.1 GROWING DEMAND FOR MASS SPECTROMETRY IN COMPREHENSIVE STUDIES ON HISTONE EPIGENETICS TO BOOST MARKET
TABLE 123 EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 124 NORTH AMERICA: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 125 EUROPE: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 ASIA PACIFIC: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 LATIN AMERICA: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 SONICATION
8.5.1 INTRODUCTION OF IMPROVED HIGH-THROUGHPUT SONICATION TECHNIQUES TO PROPEL ADOPTION
TABLE 128 EPIGENETICS MARKET FOR SONICATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 129 NORTH AMERICA: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 130 EUROPE: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 LATIN AMERICA: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 OTHER TECHNIQUES
TABLE 133 EPIGENETICS MARKET FOR OTHER TECHNIQUES, BY REGION, 2021–2028 (USD MILLION)
TABLE 134 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 135 EUROPE: EPIGENETICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 137 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021–2028 (USD MILLION)
9 EPIGENETICS MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 138 EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2 ONCOLOGY
9.2.1 GROWING EFFORTS TO DEVELOP ONCOLOGY EPIGENETIC DRUGS TO BOOST MARKET
TABLE 139 EPIGENOME-TARGETING CANCER DRUGS APPROVED OR IN CLINICAL TRIALS
TABLE 140 EPIGENETICS MARKET FOR ONCOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 141 NORTH AMERICA: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 142 EUROPE: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 144 LATIN AMERICA: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 METABOLIC DISEASES
9.3.1 EMERGING ROLE OF DNA METHYLATION IN DIABETES MANAGEMENT TO FAVOR MARKET GROWTH
TABLE 145 EPIGENETICS MARKET FOR METABOLIC DISEASES, BY REGION, 2021–2028 (USD MILLION)
TABLE 146 NORTH AMERICA: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 147 EUROPE: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 148 ASIA PACIFIC: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 149 LATIN AMERICA: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 IMMUNOLOGY
9.4.1 GROWING DEMAND FOR EPIGENETIC PRODUCTS IN TUMOR AND TRANSPLANTATION IMMUNOLOGY TO SUPPORT GROWTH
TABLE 150 EPIGENETICS MARKET FOR IMMUNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 151 NORTH AMERICA: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 152 EUROPE: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 153 ASIA PACIFIC: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 154 LATIN AMERICA: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 DEVELOPMENTAL BIOLOGY
9.5.1 INCREASING RESEARCH IN DEVELOPMENTAL BIOLOGY TO PROPEL GROWTH
TABLE 155 EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 156 NORTH AMERICA: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 157 EUROPE: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 158 ASIA PACIFIC: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 159 LATIN AMERICA: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
9.6 CARDIOVASCULAR DISEASES
9.6.1 EMERGING ROLE OF EPIGENETICS IN UNDERSTANDING ETIOLOGY OF CARDIOVASCULAR DISEASES TO BOOST ADOPTION
TABLE 160 EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION)
TABLE 161 NORTH AMERICA: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 162 EUROPE: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 163 ASIA PACIFIC: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 164 LATIN AMERICA: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
9.7 OTHER APPLICATIONS
TABLE 165 EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 166 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 167 EUROPE: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 169 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
10 EPIGENETICS MARKET, BY END USER
10.1 INTRODUCTION
TABLE 170 EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2 ACADEMIC & RESEARCH INSTITUTES
10.2.1 INCREASING GOVERNMENT INVESTMENTS & COLLABORATIONS TO CONTRIBUTE TO MARKET GROWTH
TABLE 171 EPIGENETICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 172 NORTH AMERICA: EPIGENETICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 173 EUROPE: EPIGENETICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 174 ASIA PACIFIC: EPIGENETICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 175 LATIN AMERICA: EPIGENETICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3.1 GROWING NUMBER OF CLINICAL TRIALS FOR EPIGENETICS-BASED DRUGS TO DRIVE GROWTH
TABLE 176 EPIGENETICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 177 NORTH AMERICA: EPIGENETICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 178 EUROPE: EPIGENETICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 179 ASIA PACIFIC: EPIGENETICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 180 LATIN AMERICA: EPIGENETICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
10.4 HOSPITALS & CLINICS
10.4.1 GROWING IMPORTANCE OF MEASUREMENT OF DNA METHYLATION IN HOSPITAL SETTINGS TO BOOST MARKET
TABLE 181 EPIGENETICS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 182 NORTH AMERICA: EPIGENETICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 183 EUROPE: EPIGENETICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 184 ASIA PACIFIC: EPIGENETICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 185 LATIN AMERICA: EPIGENETICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
11 EPIGENETICS MARKET, BY REGION
11.1 INTRODUCTION
TABLE 186 EPIGENETICS MARKET, BY REGION, 2021–2028 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: EPIGENETICS MARKET SNAPSHOT
TABLE 187 NORTH AMERICA: EPIGENETICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 188 NORTH AMERICA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 189 NORTH AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 NORTH AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 NORTH AMERICA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 192 NORTH AMERICA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 193 NORTH AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 194 NORTH AMERICA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.1 US
11.2.1.1 Strong network of well-established epigenetic product manufacturers to drive market growth
TABLE 195 US: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 196 US: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 US: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 US: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 199 US: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 200 US: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 201 US: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Increasing government initiatives to boost epigenetics research
TABLE 202 CANADA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 203 CANADA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 CANADA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 CANADA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 206 CANADA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 207 CANADA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 208 CANADA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3 NORTH AMERICA: RECESSION IMPACT
11.4 EUROPE
TABLE 209 EUROPE: EPIGENETICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 210 EUROPE: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 211 EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 212 EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 EUROPE: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 214 EUROPE: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 215 EUROPE: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 216 EUROPE: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.1 GERMANY
11.4.1.1 Significant investments in NGS to boost adoption of epigenetics products
TABLE 217 GERMANY: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 218 GERMANY: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 GERMANY: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 GERMANY: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 221 GERMANY: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 222 GERMANY: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 223 GERMANY: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.2 UK
11.4.2.1 Rising acceptance of genome-based diagnostic techniques by clinicians to support growth
TABLE 224 UK: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 225 UK: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 226 UK: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 227 UK: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 228 UK: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 229 UK: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 230 UK: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.3 FRANCE
11.4.3.1 Growing demand for PCR technologies to propel market growth
TABLE 231 FRANCE: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 232 FRANCE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 233 FRANCE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 234 FRANCE: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 235 FRANCE: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 236 FRANCE: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 237 FRANCE: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.4 ITALY
11.4.4.1 High incidence of cancer to support market growth
TABLE 238 ITALY: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 239 ITALY: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 240 ITALY: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 241 ITALY: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 242 ITALY: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 243 ITALY: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 244 ITALY: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION) 230 "11.4.5 SPAIN 11.4.5.1 Well-established network of research centers and universities to boost market
TABLE 245 SPAIN: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 246 SPAIN: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 247 SPAIN: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 248 SPAIN: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 249 SPAIN: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 250 SPAIN: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 251 SPAIN: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.6 REST OF EUROPE
TABLE 252 REST OF EUROPE: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 253 REST OF EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 REST OF EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 255 REST OF EUROPE: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 256 REST OF EUROPE: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 257 REST OF EUROPE: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 258 REST OF EUROPE: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5 EUROPE: RECESSION IMPACT
11.6 ASIA PACIFIC
FIGURE 31 ASIA PACIFIC: EPIGENETICS MARKET SNAPSHOT
TABLE 259 ASIA PACIFIC: EPIGENETICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 260 ASIA PACIFIC: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 261 ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 262 ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 263 ASIA PACIFIC: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 264 ASIA PACIFIC: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 265 ASIA PACIFIC: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 266 ASIA PACIFIC: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.1 JAPAN
11.6.1.1 Increasing collaborations between research & academic organizations to favor market growth
TABLE 267 JAPAN: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 268 JAPAN: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 269 JAPAN: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 270 JAPAN: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 271 JAPAN: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 272 JAPAN: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 273 JAPAN: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.2 CHINA
11.6.2.1 High demand for personalized medicine to fuel growth
TABLE 274 CHINA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 275 CHINA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 276 CHINA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 277 CHINA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 278 CHINA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 279 CHINA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 280 CHINA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.3 INDIA
11.6.3.1 Expanding base of biotechnology facilities to drive growth
TABLE 281 INDIA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 282 INDIA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 283 INDIA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 284 INDIA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 285 INDIA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 286 INDIA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 287 INDIA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.4 SOUTH KOREA
11.6.4.1 Increasing demand for epigenetic testing to boost growth
TABLE 288 SOUTH KOREA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 289 SOUTH KOREA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 290 SOUTH KOREA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 291 SOUTH KOREA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 292 SOUTH KOREA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 293 SOUTH KOREA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 294 SOUTH KOREA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.5 REST OF ASIA PACIFIC
TABLE 295 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 296 REST OF ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 297 REST OF ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 298 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 299 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 300 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 301 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.6 ASIA PACIFIC: RECESSION IMPACT
11.7 LATIN AMERICA
TABLE 302 LATIN AMERICA: EPIGENETICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 303 LATIN AMERICA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 304 LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 305 LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 306 LATIN AMERICA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 307 LATIN AMERICA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 308 LATIN AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 309 LATIN AMERICA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.7.1 BRAZIL
11.7.1.1 Increasing number of healthcare providers incorporating epigenetic testing to boost growth
TABLE 310 BRAZIL: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 311 BRAZIL: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 312 BRAZIL: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 313 BRAZIL: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 314 BRAZIL: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 315 BRAZIL: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 316 BRAZIL: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.7.2 MEXICO
11.7.2.1 Growing adoption of cutting-edge technologies to support growth
TABLE 317 MEXICO: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 318 MEXICO: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 319 MEXICO: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 320 MEXICO: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 321 MEXICO: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 322 MEXICO: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 323 MEXICO: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.7.3 REST OF LATIN AMERICA
TABLE 324 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 325 REST OF LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 326 REST OF LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 327 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 328 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 329 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 330 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.7.4 LATIN AMERICA: RECESSION IMPACT
11.8 MIDDLE EAST
11.8.1 INCREASE IN FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO BOOST GROWTH
TABLE 331 MIDDLE EAST: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 332 MIDDLE EAST: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 333 MIDDLE EAST: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 334 MIDDLE EAST: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 335 MIDDLE EAST: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 336 MIDDLE EAST: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 337 MIDDLE EAST: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.8.2 MIDDLE EAST: RECESSION IMPACT
11.9 AFRICA
11.9.1 GROWING COLLABORATIONS TO SUPPORT GROWTH IN COMING YEARS
TABLE 338 AFRICA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 339 AFRICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 340 AFRICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 341 AFRICA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 342 AFRICA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 343 AFRICA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 344 AFRICA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.9.2 AFRICA: RECESSION IMPACT
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 32 EPIGENETICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
12.3 REVENUE ANALYSIS
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
12.4 MARKET SHARE ANALYSIS
FIGURE 34 EPIGENETICS MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
TABLE 345 EPIGENETICS MARKET: DEGREE OF COMPETITION
12.5 COMPANY EVALUATION MATRIX
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 35 EPIGENETICS MARKET: COMPANY EVALUATION MATRIX, 2022
12.5.5 COMPANY FOOTPRINT ANALYSIS
TABLE 346 EPIGENETICS MARKET: PRODUCT FOOTPRINT ANALYSIS
TABLE 347 EPIGENETICS MARKET: REGIONAL FOOTPRINT ANALYSIS
12.6 START-UP/SME EVALUATION QUADRANT
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
FIGURE 36 EPIGENETICS MARKET: START-UP/SME EVALUATION MATRIX, 2022
12.6.5 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
TABLE 348 EPIGENETICS MARKET: DETAILS OF START-UP/SME PLAYERS
TABLE 349 EPIGENETICS MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS
12.7 COMPETITIVE SCENARIO & TRENDS
12.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 350 EPIGENETICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–SEPTEMBER 2023
12.7.2 DEALS
TABLE 351 EPIGENETICS MARKET: DEALS, JANUARY 2021–SEPTEMBER 2023
12.7.3 OTHER DEVELOPMENTS
TABLE 352 EPIGENETICS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2023
13 COMPANY PROFILES
(Business overview, Products offered, Recent Developments, MNM view)*
13.1 KEY MARKET PLAYERS
13.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 353 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
13.1.2 ILLUMINA, INC.
TABLE 354 ILLUMINA, INC.: BUSINESS OVERVIEW
FIGURE 38 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
13.1.3 MERCK KGAA
TABLE 355 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2022)
13.1.4 PACBIO
TABLE 356 PACBIO: BUSINESS OVERVIEW
FIGURE 40 PACBIO: COMPANY SNAPSHOT (2022)
13.1.5 ABCAM PLC
TABLE 357 ABCAM PLC: BUSINESS OVERVIEW
FIGURE 41 ABCAM PLC: COMPANY SNAPSHOT (2022)
13.1.6 BIO-RAD LABORATORIES, INC.
TABLE 358 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
13.1.7 ACTIVE MOTIF INC.
TABLE 359 ACTIVE MOTIF INC.: BUSINESS OVERVIEW
13.1.8 NEW ENGLAND BIOLABS
TABLE 360 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
13.1.9 QIAGEN
TABLE 361 QIAGEN: BUSINESS OVERVIEW
FIGURE 43 QIAGEN: COMPANY SNAPSHOT (2022)
13.1.10 ZYMO RESEARCH CORPORATION
TABLE 362 ZYMO RESEARCH CORPORATION: BUSINESS OVERVIEW
13.1.11 REVVITY
TABLE 363 REVVITY: BUSINESS OVERVIEW
FIGURE 44 REVVITY: COMPANY SNAPSHOT (2022)
13.1.12 DIAGENODE SA (A HOLOGIC COMPANY)
TABLE 364 DIAGENODE SA (A HOLOGIC COMPANY): BUSINESS OVERVIEW
13.1.13 F. HOFFMANN-LA ROCHE LTD.
TABLE 365 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
13.1.14 PROMEGA CORPORATION
TABLE 366 PROMEGA CORPORATION: BUSINESS OVERVIEW
13.1.15 EPIGENTEK GROUP INC.
TABLE 367 EPIGENTEK GROUP INC.: BUSINESS OVERVIEW
13.2 OTHER PLAYERS
13.2.1 EPICYPHER
13.2.2 FIOS GENOMICS
13.2.3 GENOMESCAN
13.2.4 CREATIVE BIOGENE
13.2.5 BPS BIOSCIENCE, INC.
13.2.6 ABNOVA CORPORATION
13.2.7 CREATIVE DIAGNOSTICS
13.2.8 BIOMODAL (FORMERLY CAMBRIDGE EPIGENETIX)
13.2.9 INTEGRATED DNA TECHNOLOGIES, INC.
13.2.10 NOVOGENE CO., LTD.
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 RESEARCH LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION: EPIGENETICS MARKET (2022)
FIGURE 4 APPROACH 1: REVENUE SHARE ANALYSIS
FIGURE 5 REVENUE SHARE ANALYSIS OF THERMO FISHER SCIENTIFIC INC.: EPIGENETICS MARKET (2022)
2.2.1 PRIMARY INSIGHTS
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENTAL ASSESSMENT: EPIGENETICS MARKET
FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
FIGURE 8 CAGR PROJECTION: EPIGENETICS MARKET
FIGURE 9 GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT: EPIGENETICS MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2021–2028 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 11 EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 EPIGENETICS MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)
FIGURE 13 EPIGENETICS MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
FIGURE 14 EPIGENETICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 15 EPIGENETICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF EPIGENETICS MARKET
4 PREMIUM INSIGHTS
4.1 EPIGENETICS MARKET OVERVIEW
FIGURE 17 DECLINING SEQUENCING COSTS & TIME TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
4.2 NORTH AMERICA: EPIGENETICS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 18 KITS & REAGENTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN EPIGENETICS MARKET IN 2022
4.3 EPIGENETICS MARKET SHARE, BY PRODUCT & SERVICE, 2023 VS. 2028
FIGURE 19 KITS & REAGENTS SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
4.4 EPIGENETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATES FROM 2023 TO 2028
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 EPIGENETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 IMPACT ANALYSIS: EPIGENETICS MARKET
5.2.1 DRIVERS
5.2.1.1 Growing investments in research & development
5.2.1.2 Declining sequencing costs & time
FIGURE 22 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2020
5.2.1.3 Favorable government initiatives and funding for epigenetics research
5.2.1.4 Technological advancements in epigenetics research
5.2.1.5 Rising demand for epigenetic-based therapeutics
FIGURE 23 NUMBER OF CANCER CASES IN US, 2017–2022
5.2.2 RESTRAINTS
5.2.2.1 Limited applications of epigenomic data in toxicology
5.2.2.2 Data privacy concerns and security issues
5.2.3 OPPORTUNITIES
5.2.3.1 Expanding applications of epigenetics
5.2.3.2 Integration of artificial intelligence and machine learning algorithms
5.2.4 CHALLENGES
5.2.4.1 Concerns regarding quality of antibodies
5.2.4.2 Challenges associated with epigenetic editing
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 REVENUE SHIFT AND NEW REVENUE POCKETS FOR EPIGENETICS PROVIDERS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE OF PRODUCTS, BY KEY PLAYER
TABLE 5 AVERAGE SELLING PRICE OF PRODUCTS, BY KEY PLAYER
5.4.2 AVERAGE SELLING PRICE TREND
5.5 TECHNOLOGY ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASES CONTRIBUTE MAXIMUM VALUE
5.7 ECOSYSTEM MAP
FIGURE 26 ECOSYSTEM MAP
TABLE 6 ROLE IN ECOSYSTEM: EPIGENETICS MARKET
5.8 REGULATORY ANALYSIS
TABLE 7 KEY REGULATORY AGENCIES
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 MIDDLE EAST: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 14 PORTER’S FIVE FORCES ANALYSIS: EPIGENETICS MARKET
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 PATENT ANALYSIS
FIGURE 27 PATENT APPLICATIONS FOR EPIGENETICS, NOVEMBER 2013–NOVEMBER 2023
TABLE 15 INDICATIVE LIST OF PATENTS: EPIGENETICS MARKET
5.11 KEY CONFERENCES & EVENTS
TABLE 16 DETAILED LIST OF KEY CONFERENCES & EVENTS, 2023–2024
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EPIGENETICS
5.12.2 BUYING CRITERIA FOR EPIGENETICS
FIGURE 29 KEY BUYING CRITERIA FOR END USERS
6 EPIGENETICS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 17 EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 KITS & REAGENTS
TABLE 18 EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 19 EPIGENETICS MARKET FOR KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 20 NORTH AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 ANTIBODIES
6.2.1.1 Growing demand for recombinant antibodies for detection of epigenetic targets to propel growth
TABLE 24 EPIGENETICS MARKET FOR ANTIBODIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 25 NORTH AMERICA: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 EUROPE: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 LATIN AMERICA: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 CHIP-SEQUENCING KITS & REAGENTS
6.2.2.1 Versatile applications of chromatin immunoprecipitation (ChIP) pertaining to epigenetic regulatory systems to boost demand
TABLE 29 EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 NORTH AMERICA: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 EUROPE: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 ASIA PACIFIC: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 LATIN AMERICA: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 BISULFITE CONVERSION KITS & REAGENTS
6.2.3.1 Effective outcomes associated with bisulfite conversion to drive demand
TABLE 34 EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 LATIN AMERICA: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 WHOLE-GENOME AMPLIFICATION KITS & REAGENTS
6.2.4.1 Ability of whole-genome amplification to maintain relative proportions of genes in original pool to drive adoption
TABLE 39 EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 40 NORTH AMERICA: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 EUROPE: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 ASIA PACIFIC: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 LATIN AMERICA: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.5 5-HMC & 5-MC ANALYSIS KITS & REAGENTS
6.2.5.1 Introduction of unique kits for 5-mC and 5-hmC analysis to support growth
TABLE 44 EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 45 NORTH AMERICA: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 EUROPE: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 ASIA PACIFIC: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 LATIN AMERICA: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.6 HISTONES
6.2.6.1 Emerging importance of chromatin-associated proteins and histones in epigenetic research to drive segmental growth
TABLE 49 EPIGENETICS MARKET FOR HISTONES, BY REGION, 2021–2028 (USD MILLION)
TABLE 50 NORTH AMERICA: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 51 EUROPE: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 ASIA PACIFIC: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 LATIN AMERICA: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.7 OTHER KITS & REAGENTS
TABLE 54 EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 55 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 56 EUROPE: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 ENZYMES
TABLE 59 EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 60 EPIGENETICS MARKET FOR ENZYMES, BY REGION, 2021–2028 (USD MILLION)
TABLE 61 NORTH AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 DNA-MODIFYING ENZYMES
6.3.1.1 Broadening applications of DNA methylation to favor market growth
TABLE 65 EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY REGION, 2021–2028 (USD MILLION)
TABLE 66 NORTH AMERICA: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 EUROPE: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 ASIA PACIFIC: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 LATIN AMERICA: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 PROTEIN-MODIFYING ENZYMES
6.3.2.1 Increasing pipeline of epigenetics-based drugs targeting histone-modifying enzymes to drive segmental growth
TABLE 70 EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY REGION, 2021–2028 (USD MILLION)
TABLE 71 NORTH AMERICA: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 72 EUROPE: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 ASIA PACIFIC: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 LATIN AMERICA: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 OTHER ENZYMES
TABLE 75 EPIGENETICS MARKET FOR OTHER ENZYMES, BY REGION, 2021–2028 (USD MILLION)
TABLE 76 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 77 EUROPE: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 INSTRUMENTS & ACCESSORIES
6.4.1 WIDE USAGE OF NGS INSTRUMENTS AND SONICATORS TO PROPEL GROWTH
TABLE 80 EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 81 NORTH AMERICA: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 EUROPE: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 ASIA PACIFIC: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 LATIN AMERICA: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 SOFTWARE
6.5.1 DEVELOPMENT OF VIABLE SOFTWARE SOLUTIONS FOR DNA METHYLATION AND RNA ANALYSIS TO PROPEL GROWTH
TABLE 85 EPIGENETICS MARKET FOR SOFTWARE, BY REGION, 2021–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 EUROPE: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 LATIN AMERICA: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
6.6 SERVICES
6.6.1 EXPANDING POOL OF SERVICE PROVIDERS TO DRIVE GROWTH
TABLE 90 EPIGENETICS MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION)
TABLE 91 NORTH AMERICA: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 EUROPE: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 ASIA PACIFIC: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 LATIN AMERICA: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
7 EPIGENETICS MARKET, BY METHOD
7.1 INTRODUCTION
TABLE 95 EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
7.2 DNA METHYLATION
7.2.1 INCREASING R&D ACTIVITIES TO EXPLORE POTENTIAL OF DNA METHYLATION TO DRIVE MARKET GROWTH
TABLE 96 EPIGENETICS MARKET FOR DNA METHYLATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 98 EUROPE: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 ASIA PACIFIC: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 LATIN AMERICA: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 HISTONE MODIFICATIONS
7.3.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE SEGMENTAL GROWTH
TABLE 101 COMMON HISTONE MODIFICATIONS AND RESPECTIVE LOCATIONS
TABLE 102 EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 103 NORTH AMERICA: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 106 LATIN AMERICA: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 OTHER METHODS
TABLE 107 EPIGENETICS MARKET FOR OTHER METHODS, BY REGION, 2021–2028 (USD MILLION)
TABLE 108 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 109 EUROPE: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2021–2028 (USD MILLION)
8 EPIGENETICS MARKET, BY TECHNIQUE
8.1 INTRODUCTION
TABLE 112 EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
8.2 NGS
8.2.1 ABILITY TO OFFER COMPREHENSIVE EPIGENETIC PROFILES TO PROPEL DEMAND FOR NGS TECHNIQUE
TABLE 113 EPIGENETICS MARKET FOR NGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 114 NORTH AMERICA: EPIGENETICS MARKET FOR NGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 115 EUROPE: EPIGENETICS MARKET FOR NGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 116 ASIA PACIFIC: EPIGENETICS MARKET FOR NGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 LATIN AMERICA: EPIGENETICS MARKET FOR NGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 PCR & QPCR
8.3.1 RISING NUMBER OF PCR-BASED EPIGENETICS SERVICE PROVIDERS TO DRIVE GROWTH
TABLE 118 EPIGENETICS MARKET FOR PCR & QPCR, BY REGION, 2021–2028 (USD MILLION)
TABLE 119 NORTH AMERICA: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 120 EUROPE: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 ASIA PACIFIC: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 LATIN AMERICA: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 MASS SPECTROMETRY
8.4.1 GROWING DEMAND FOR MASS SPECTROMETRY IN COMPREHENSIVE STUDIES ON HISTONE EPIGENETICS TO BOOST MARKET
TABLE 123 EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 124 NORTH AMERICA: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 125 EUROPE: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 ASIA PACIFIC: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 LATIN AMERICA: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 SONICATION
8.5.1 INTRODUCTION OF IMPROVED HIGH-THROUGHPUT SONICATION TECHNIQUES TO PROPEL ADOPTION
TABLE 128 EPIGENETICS MARKET FOR SONICATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 129 NORTH AMERICA: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 130 EUROPE: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 LATIN AMERICA: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 OTHER TECHNIQUES
TABLE 133 EPIGENETICS MARKET FOR OTHER TECHNIQUES, BY REGION, 2021–2028 (USD MILLION)
TABLE 134 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 135 EUROPE: EPIGENETICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 137 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021–2028 (USD MILLION)
9 EPIGENETICS MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 138 EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2 ONCOLOGY
9.2.1 GROWING EFFORTS TO DEVELOP ONCOLOGY EPIGENETIC DRUGS TO BOOST MARKET
TABLE 139 EPIGENOME-TARGETING CANCER DRUGS APPROVED OR IN CLINICAL TRIALS
TABLE 140 EPIGENETICS MARKET FOR ONCOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 141 NORTH AMERICA: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 142 EUROPE: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 144 LATIN AMERICA: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 METABOLIC DISEASES
9.3.1 EMERGING ROLE OF DNA METHYLATION IN DIABETES MANAGEMENT TO FAVOR MARKET GROWTH
TABLE 145 EPIGENETICS MARKET FOR METABOLIC DISEASES, BY REGION, 2021–2028 (USD MILLION)
TABLE 146 NORTH AMERICA: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 147 EUROPE: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 148 ASIA PACIFIC: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 149 LATIN AMERICA: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 IMMUNOLOGY
9.4.1 GROWING DEMAND FOR EPIGENETIC PRODUCTS IN TUMOR AND TRANSPLANTATION IMMUNOLOGY TO SUPPORT GROWTH
TABLE 150 EPIGENETICS MARKET FOR IMMUNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 151 NORTH AMERICA: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 152 EUROPE: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 153 ASIA PACIFIC: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 154 LATIN AMERICA: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 DEVELOPMENTAL BIOLOGY
9.5.1 INCREASING RESEARCH IN DEVELOPMENTAL BIOLOGY TO PROPEL GROWTH
TABLE 155 EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 156 NORTH AMERICA: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 157 EUROPE: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 158 ASIA PACIFIC: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 159 LATIN AMERICA: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
9.6 CARDIOVASCULAR DISEASES
9.6.1 EMERGING ROLE OF EPIGENETICS IN UNDERSTANDING ETIOLOGY OF CARDIOVASCULAR DISEASES TO BOOST ADOPTION
TABLE 160 EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION)
TABLE 161 NORTH AMERICA: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 162 EUROPE: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 163 ASIA PACIFIC: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 164 LATIN AMERICA: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
9.7 OTHER APPLICATIONS
TABLE 165 EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 166 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 167 EUROPE: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 169 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
10 EPIGENETICS MARKET, BY END USER
10.1 INTRODUCTION
TABLE 170 EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2 ACADEMIC & RESEARCH INSTITUTES
10.2.1 INCREASING GOVERNMENT INVESTMENTS & COLLABORATIONS TO CONTRIBUTE TO MARKET GROWTH
TABLE 171 EPIGENETICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 172 NORTH AMERICA: EPIGENETICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 173 EUROPE: EPIGENETICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 174 ASIA PACIFIC: EPIGENETICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 175 LATIN AMERICA: EPIGENETICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3.1 GROWING NUMBER OF CLINICAL TRIALS FOR EPIGENETICS-BASED DRUGS TO DRIVE GROWTH
TABLE 176 EPIGENETICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 177 NORTH AMERICA: EPIGENETICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 178 EUROPE: EPIGENETICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 179 ASIA PACIFIC: EPIGENETICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 180 LATIN AMERICA: EPIGENETICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
10.4 HOSPITALS & CLINICS
10.4.1 GROWING IMPORTANCE OF MEASUREMENT OF DNA METHYLATION IN HOSPITAL SETTINGS TO BOOST MARKET
TABLE 181 EPIGENETICS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 182 NORTH AMERICA: EPIGENETICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 183 EUROPE: EPIGENETICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 184 ASIA PACIFIC: EPIGENETICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 185 LATIN AMERICA: EPIGENETICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
11 EPIGENETICS MARKET, BY REGION
11.1 INTRODUCTION
TABLE 186 EPIGENETICS MARKET, BY REGION, 2021–2028 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: EPIGENETICS MARKET SNAPSHOT
TABLE 187 NORTH AMERICA: EPIGENETICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 188 NORTH AMERICA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 189 NORTH AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 NORTH AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 NORTH AMERICA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 192 NORTH AMERICA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 193 NORTH AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 194 NORTH AMERICA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.1 US
11.2.1.1 Strong network of well-established epigenetic product manufacturers to drive market growth
TABLE 195 US: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 196 US: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 US: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 US: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 199 US: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 200 US: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 201 US: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Increasing government initiatives to boost epigenetics research
TABLE 202 CANADA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 203 CANADA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 CANADA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 CANADA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 206 CANADA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 207 CANADA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 208 CANADA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3 NORTH AMERICA: RECESSION IMPACT
11.4 EUROPE
TABLE 209 EUROPE: EPIGENETICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 210 EUROPE: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 211 EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 212 EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 EUROPE: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 214 EUROPE: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 215 EUROPE: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 216 EUROPE: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.1 GERMANY
11.4.1.1 Significant investments in NGS to boost adoption of epigenetics products
TABLE 217 GERMANY: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 218 GERMANY: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 GERMANY: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 GERMANY: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 221 GERMANY: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 222 GERMANY: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 223 GERMANY: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.2 UK
11.4.2.1 Rising acceptance of genome-based diagnostic techniques by clinicians to support growth
TABLE 224 UK: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 225 UK: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 226 UK: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 227 UK: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 228 UK: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 229 UK: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 230 UK: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.3 FRANCE
11.4.3.1 Growing demand for PCR technologies to propel market growth
TABLE 231 FRANCE: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 232 FRANCE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 233 FRANCE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 234 FRANCE: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 235 FRANCE: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 236 FRANCE: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 237 FRANCE: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.4 ITALY
11.4.4.1 High incidence of cancer to support market growth
TABLE 238 ITALY: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 239 ITALY: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 240 ITALY: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 241 ITALY: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 242 ITALY: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 243 ITALY: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 244 ITALY: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION) 230 "11.4.5 SPAIN 11.4.5.1 Well-established network of research centers and universities to boost market
TABLE 245 SPAIN: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 246 SPAIN: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 247 SPAIN: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 248 SPAIN: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 249 SPAIN: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 250 SPAIN: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 251 SPAIN: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.6 REST OF EUROPE
TABLE 252 REST OF EUROPE: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 253 REST OF EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 REST OF EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 255 REST OF EUROPE: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 256 REST OF EUROPE: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 257 REST OF EUROPE: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 258 REST OF EUROPE: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5 EUROPE: RECESSION IMPACT
11.6 ASIA PACIFIC
FIGURE 31 ASIA PACIFIC: EPIGENETICS MARKET SNAPSHOT
TABLE 259 ASIA PACIFIC: EPIGENETICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 260 ASIA PACIFIC: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 261 ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 262 ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 263 ASIA PACIFIC: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 264 ASIA PACIFIC: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 265 ASIA PACIFIC: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 266 ASIA PACIFIC: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.1 JAPAN
11.6.1.1 Increasing collaborations between research & academic organizations to favor market growth
TABLE 267 JAPAN: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 268 JAPAN: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 269 JAPAN: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 270 JAPAN: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 271 JAPAN: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 272 JAPAN: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 273 JAPAN: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.2 CHINA
11.6.2.1 High demand for personalized medicine to fuel growth
TABLE 274 CHINA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 275 CHINA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 276 CHINA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 277 CHINA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 278 CHINA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 279 CHINA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 280 CHINA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.3 INDIA
11.6.3.1 Expanding base of biotechnology facilities to drive growth
TABLE 281 INDIA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 282 INDIA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 283 INDIA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 284 INDIA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 285 INDIA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 286 INDIA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 287 INDIA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.4 SOUTH KOREA
11.6.4.1 Increasing demand for epigenetic testing to boost growth
TABLE 288 SOUTH KOREA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 289 SOUTH KOREA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 290 SOUTH KOREA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 291 SOUTH KOREA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 292 SOUTH KOREA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 293 SOUTH KOREA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 294 SOUTH KOREA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.5 REST OF ASIA PACIFIC
TABLE 295 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 296 REST OF ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 297 REST OF ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 298 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 299 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 300 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 301 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.6 ASIA PACIFIC: RECESSION IMPACT
11.7 LATIN AMERICA
TABLE 302 LATIN AMERICA: EPIGENETICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 303 LATIN AMERICA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 304 LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 305 LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 306 LATIN AMERICA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 307 LATIN AMERICA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 308 LATIN AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 309 LATIN AMERICA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.7.1 BRAZIL
11.7.1.1 Increasing number of healthcare providers incorporating epigenetic testing to boost growth
TABLE 310 BRAZIL: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 311 BRAZIL: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 312 BRAZIL: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 313 BRAZIL: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 314 BRAZIL: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 315 BRAZIL: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 316 BRAZIL: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.7.2 MEXICO
11.7.2.1 Growing adoption of cutting-edge technologies to support growth
TABLE 317 MEXICO: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 318 MEXICO: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 319 MEXICO: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 320 MEXICO: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 321 MEXICO: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 322 MEXICO: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 323 MEXICO: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.7.3 REST OF LATIN AMERICA
TABLE 324 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 325 REST OF LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 326 REST OF LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 327 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 328 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 329 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 330 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.7.4 LATIN AMERICA: RECESSION IMPACT
11.8 MIDDLE EAST
11.8.1 INCREASE IN FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO BOOST GROWTH
TABLE 331 MIDDLE EAST: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 332 MIDDLE EAST: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 333 MIDDLE EAST: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 334 MIDDLE EAST: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 335 MIDDLE EAST: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 336 MIDDLE EAST: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 337 MIDDLE EAST: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.8.2 MIDDLE EAST: RECESSION IMPACT
11.9 AFRICA
11.9.1 GROWING COLLABORATIONS TO SUPPORT GROWTH IN COMING YEARS
TABLE 338 AFRICA: EPIGENETICS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 339 AFRICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 340 AFRICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 341 AFRICA: EPIGENETICS MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 342 AFRICA: EPIGENETICS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 343 AFRICA: EPIGENETICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 344 AFRICA: EPIGENETICS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.9.2 AFRICA: RECESSION IMPACT
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 32 EPIGENETICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
12.3 REVENUE ANALYSIS
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
12.4 MARKET SHARE ANALYSIS
FIGURE 34 EPIGENETICS MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
TABLE 345 EPIGENETICS MARKET: DEGREE OF COMPETITION
12.5 COMPANY EVALUATION MATRIX
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 35 EPIGENETICS MARKET: COMPANY EVALUATION MATRIX, 2022
12.5.5 COMPANY FOOTPRINT ANALYSIS
TABLE 346 EPIGENETICS MARKET: PRODUCT FOOTPRINT ANALYSIS
TABLE 347 EPIGENETICS MARKET: REGIONAL FOOTPRINT ANALYSIS
12.6 START-UP/SME EVALUATION QUADRANT
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
FIGURE 36 EPIGENETICS MARKET: START-UP/SME EVALUATION MATRIX, 2022
12.6.5 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
TABLE 348 EPIGENETICS MARKET: DETAILS OF START-UP/SME PLAYERS
TABLE 349 EPIGENETICS MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS
12.7 COMPETITIVE SCENARIO & TRENDS
12.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 350 EPIGENETICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–SEPTEMBER 2023
12.7.2 DEALS
TABLE 351 EPIGENETICS MARKET: DEALS, JANUARY 2021–SEPTEMBER 2023
12.7.3 OTHER DEVELOPMENTS
TABLE 352 EPIGENETICS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2023
13 COMPANY PROFILES
(Business overview, Products offered, Recent Developments, MNM view)*
13.1 KEY MARKET PLAYERS
13.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 353 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
13.1.2 ILLUMINA, INC.
TABLE 354 ILLUMINA, INC.: BUSINESS OVERVIEW
FIGURE 38 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
13.1.3 MERCK KGAA
TABLE 355 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2022)
13.1.4 PACBIO
TABLE 356 PACBIO: BUSINESS OVERVIEW
FIGURE 40 PACBIO: COMPANY SNAPSHOT (2022)
13.1.5 ABCAM PLC
TABLE 357 ABCAM PLC: BUSINESS OVERVIEW
FIGURE 41 ABCAM PLC: COMPANY SNAPSHOT (2022)
13.1.6 BIO-RAD LABORATORIES, INC.
TABLE 358 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
13.1.7 ACTIVE MOTIF INC.
TABLE 359 ACTIVE MOTIF INC.: BUSINESS OVERVIEW
13.1.8 NEW ENGLAND BIOLABS
TABLE 360 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
13.1.9 QIAGEN
TABLE 361 QIAGEN: BUSINESS OVERVIEW
FIGURE 43 QIAGEN: COMPANY SNAPSHOT (2022)
13.1.10 ZYMO RESEARCH CORPORATION
TABLE 362 ZYMO RESEARCH CORPORATION: BUSINESS OVERVIEW
13.1.11 REVVITY
TABLE 363 REVVITY: BUSINESS OVERVIEW
FIGURE 44 REVVITY: COMPANY SNAPSHOT (2022)
13.1.12 DIAGENODE SA (A HOLOGIC COMPANY)
TABLE 364 DIAGENODE SA (A HOLOGIC COMPANY): BUSINESS OVERVIEW
13.1.13 F. HOFFMANN-LA ROCHE LTD.
TABLE 365 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
13.1.14 PROMEGA CORPORATION
TABLE 366 PROMEGA CORPORATION: BUSINESS OVERVIEW
13.1.15 EPIGENTEK GROUP INC.
TABLE 367 EPIGENTEK GROUP INC.: BUSINESS OVERVIEW
13.2 OTHER PLAYERS
13.2.1 EPICYPHER
13.2.2 FIOS GENOMICS
13.2.3 GENOMESCAN
13.2.4 CREATIVE BIOGENE
13.2.5 BPS BIOSCIENCE, INC.
13.2.6 ABNOVA CORPORATION
13.2.7 CREATIVE DIAGNOSTICS
13.2.8 BIOMODAL (FORMERLY CAMBRIDGE EPIGENETIX)
13.2.9 INTEGRATED DNA TECHNOLOGIES, INC.
13.2.10 NOVOGENE CO., LTD.
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
